UM
REGN icon

UniSuper Management’s Regeneron Pharmaceuticals REGN Stock Holding History

UniSuper Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.05M Buy
11,299
+2,722
+32% +$1.85M 0.04% 249
2026
Q1 		$6.63M Sell
8,577
-62
-0.7% -$47.5K 0.04% 206
2025
Q4 		$6.67M Sell
8,639
-920
-10% -$625K 0.04% 205
2025
Q3 		$5.37M Buy
9,559
+1,191
+14% +$673K 0.03% 262
2025
Q2 		$4.39M Buy
8,368
+566
+7% +$316K 0.03% 271
2025
Q1 		$4.95M Buy
7,802
+496
+7% +$341K 0.04% 228
2024
Q4 		$5.2M Buy
7,306
+2,013
+38% +$1.69M 0.04% 219
2024
Q3 		$5.56M Buy
5,293
+144
+3% +$160K 0.04% 214
2024
Q2 		$5.41M Buy
5,149
+2,740
+114% +$2.66M 0.04% 204
2024
Q1 		$2.32M Buy
2,409
+1,530
+174% +$1.45M 0.02% 231
2023
Q4 		$772K Sell
879
-757
-46% -$623K 0.01% 285
2023
Q3 		$1.35M Sell
1,636
-198
-11% -$156K 0.02% 246
2023
Q2 		$1.32M Buy
+1,834
New +$1.41M 0.02% 251

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

UniSuper Management's REGN Position: Q2 2026 in Review

UniSuper Management increased its Regeneron Pharmaceuticals (REGN) stake by 32% in Q2 2026, buying an estimated $1.85M and bringing the position to 11,299 shares worth $7.05M. The position accounts for 0.04% of the portfolio, ranked #249.

UniSuper Management first reported a position in REGN in Q2 2023 and has held it in 13 quarters since. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • UniSuper Management held 11,299 shares of Regeneron Pharmaceuticals worth $7.05M as of Q2 2026.
  • UniSuper Management bought 2,722 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $1.85M.
  • Regeneron Pharmaceuticals made up 0.04% of UniSuper Management's portfolio in Q2 2026, its #249 holding.
  • UniSuper Management first reported a position in Regeneron Pharmaceuticals in Q2 2023 and has held it in 13 quarters since.
  • 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on UniSuper Management's 13F filing for Q2 2026, filed 14 Aug 2026.